• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 TITANIUM IMPLANTABLE PORT, HICKMAN SINGLE-LUMEN, 9.6F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 TITANIUM IMPLANTABLE PORT, HICKMAN SINGLE-LUMEN, 9.6F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Model Number 0602230
Medical Device Problem Codes Fluid/Blood Leak (1250); Fracture (1260); Material Separation (1562)
Health Effect - Clinical Codes Extravasation (1842); Embolism/Embolus (4438); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/12/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer.The investigation of the reported event is currently underway.Medical device: expiry date: 03/2026.
 
Event or Problem Description
It was reported that approximately one month post port placement procedure via internal jugular vein, the catheter was allegedly separated and had break.It was further reported that the device allegedly had leakage at proximal end.Reportedly, patient experienced extravasation.The current status of the patient is stable.
 
Additional Manufacturer Narrative
H10: additional information was received and the file was reassessed for reportability and determined to be reportable as serious injury.H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer.The investigation of the reported event is currently underway.H10: b5, d4 (expiry date: 03/2026).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that approximately one month post port placement procedure via internal jugular vein, the catheter was allegedly separated and had break.It was further reported that the device allegedly had leakage at proximal end.Reportedly, catheter was allegedly embolized and the patient experienced extravasation.The current status of the patient is stable.
 
Event or Problem Description
It was reported that fifty five days post port placement procedure via internal jugular vein, the catheter was allegedly separated and had break.It was further reported that the device allegedly had leakage at proximal end.Reportedly, catheter was allegedly embolized and the patient experienced extravasation.The current status of the patient is stable.
 
Additional Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: one titanium low profile implantable port attached to a catheter were returned for evaluation.Functional, gross visual, tactile and microscopic visual evaluations were performed.The investigation is confirmed for the reported fracture and fluid leak issues, as the proximal end of the attached catheter was observed to have three splits.The investigation is unconfirmed for the reported material separation issues, as no complete separation was noted on the catheter.A definitive root cause could not be determined based upon the available information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : see h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TITANIUM IMPLANTABLE PORT, HICKMAN SINGLE-LUMEN, 9.6F
Common Device Name
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key15571555
Report Number3006260740-2022-03941
Device Sequence Number20352863
Product Code LJT
UDI-Device Identifier00801741025563
UDI-Public(01)00801741025563
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
K050310
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number0602230
Device Catalogue Number0602230
Device Lot NumberREFV1377
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/04/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 09/13/2022
Supplement Date Received by Manufacturer09/21/2022
12/05/2022
Initial Report FDA Received Date10/10/2022
Supplement Report FDA Received Date10/19/2022
12/10/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening;
Patient Age51 YR
Patient SexFemale
Patient Weight55 KG
-
-